ABUS vs INTC Stock Comparison

ABUS currently leads INTC in this stock comparison, with AIQ scores of 70 vs 36. The clearest difference is value.

Market data as of Nov 15, 2026 market close· AIQ score gap 34 points
ABUS
Healthcare
vs
INTC
Technology
ABUS
Arbutus Biopharma Corp
Leads
Price
$4.09
Day move
+1.49%
AIQ Score
70/100
Best edge
Value
Sector
Healthcare
INTC
Intel Corp.
Price
$59.66
Day move
-2.52%
AIQ Score
36/100
Best edge
Balanced
Sector
Technology

What is the main difference between ABUS and INTC?

ABUS leads the current stock comparison as Arbutus Biopharma Corp, with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Arbutus Biopharma Corp vs Intel Corp.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 62/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 10/10

ABUS leads

ABUS leads by 34 AIQ points, primarily on Value and Quality, and the lead has widened from 16 points over 30 sessions.

Stable: 5 of 5 evidence groups support ABUS, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 5 of 5Comparison trend: Strengthening
ABUS

Arbutus Biopharma Corp

Leads
AIQ Score
70/100
AIQ Edge Score
9/10
INTC

Intel Corp.

AIQ Score
36/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors ABUS over INTC, 70 versus 36 as of Nov 15, 2026. ABUS's advantage is driven primarily by stronger value and quality. ABUS also shows the stronger technical structure relative to its 50-day moving average. 5 of 5 covered evidence groups favor ABUS today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ABUS lead: Strengthening — the AIQ differential moved from 16 to 34 points over 30 sessions. ABUS leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Arbutus Biopharma Corp and Intel Corp. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ABUS
+24.3%
INTC
+28.1%

Total return comparison

Growth of $10,000, distributions reinvested

ABUS $12,432 · INTC $12,812

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ABUS and INTC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ABUS advantage
0
INTC advantage
  • Value92 vs 47
    ABUS +45
  • Quality82 vs 38
    ABUS +44
  • Risk Resilience62 vs 29
    ABUS +33
  • Momentum51 vs 30
    ABUS +21

5 of 5 evidence groups favor ABUS. ABUS’s edge is concentrated in value and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ABUS0 AIQ

No factor moved materially.

New signals

  • Death Cross Active — bearish, trend, long horizon (0.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
INTC0 AIQ

Largest factor move: Quality -1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 5 active signals are unchanged.

ABUS's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — ABUS and INTC both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ABUS

ABUS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

INTC

INTC on combined revenue and EPS growth.

Value

ABUS

ABUS on the peer-relative Value factor, by 45 points.

Momentum

ABUS

ABUS on the Momentum factor, by 21 points.

Lower downside

ABUS

ABUS on Risk Resilience, by 33 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureABUSINTCNote
Implied upside to target—+75.8%Level
Target dispersion—+71.5%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering151Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

5 of 5 covered evidence groups favor ABUS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreABUS70 vs 36
FundamentalsABUSon balancerevenue growth -70.5% vs 2.4%; EPS growth 11% vs 129.2%; TTM ROE 68.9% vs 2.9%; gross margin 100% vs 40.2%; operating margin 79.9% vs 3.2% — ABUS takes 3 of 5 decided legs, not all of them
ValuationABUSValue 92 vs 47
TechnicalsABUSPrice vs 50-day -8.3% vs -37.2%; vs 200-day -8.7% vs -31.7%
Risk ResilienceABUSRisk Resilience 62 vs 29
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABUS and INTC and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 34 points. (supports the conclusion holding)
  • 5 of 5 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ABUS.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ABUS lead: Strengthening — the AIQ differential moved from 16 to 34 points over 30 sessions.

May 27ABUS leads above the line · INTC leads belowNov 13
Today
ABUS +34
70 vs 36
7 sessions ago
ABUS +32
68 vs 36
30 sessions ago
ABUS +16
68 vs 52
90 sessions ago
ABUS +22
72 vs 50

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ABUSConflicted

2 bullish / 3 bearish / 1 neutral, conflicted

Only ABUS

  • Death Cross Active — bearish, trend, long horizon (0.45%)
  • Distribution Pattern — bearish, volume, medium horizon (1.36x)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
INTCConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only INTC

  • Golden Cross Active — bullish, trend, long horizon (8.67%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

ABUS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ABUSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.49%, AIQ 0 points).

INTCNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.52%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1INTC closes the Value gap — currently 45 points behind, the largest single contributor to ABUS's edge.
  2. 2INTC's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3ABUS's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ABUS leads on balance
MetricABUSINTC
Revenue growth (YoY)-70.5%2.4%
EPS growth (YoY)11%129.2%
Gross margin100%40.2%
Operating margin79.9%3.2%
Return on equity (TTM)68.9%2.9%
Debt to equity00.44

Performance

ABUS leads 4 of 6 windows
MetricABUSINTC
1 week (5 sessions)11.9%6%
1 month (20 sessions)-3.1%-33.6%
3 months (63 sessions)-13.2%-42.4%
6 months (126 sessions)-3.5%-45.2%
Year to date-15%61.7%
1 year (252 sessions)-15.5%57.5%

Technicals

ABUS has the stronger structure
MetricABUSINTC
RSI (14)48.532.4
ADX (14)29.241
Price vs 50-day-8.3%-37.2%
Price vs 200-day-8.7%-31.7%
Volatility (1M, annualized)52.1%128.4%

Risk

ABUS is the more resilient
MetricABUSINTC
Beta1.193.21
Sharpe ratio-0.090.98
Sortino ratio-0.131.49
Max drawdown-30%-62.9%
Current drawdown-21.6%-57.7%
Annualized volatility45.9%84.7%
Value at risk (95%)-4.4%-6.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ABUS or INTC?

On the Algovestiq AIQ Score, ABUS is the stronger of the two as of Nov 15, 2026, scoring 70 against INTC's 36. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ABUS or INTC the better buy right now?

ABUS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor ABUS over INTC?

The composite weights Quality, Value, Momentum and Risk Resilience. ABUS leads Value by 45 points; ABUS leads Quality by 44 points; ABUS leads Risk Resilience by 33 points. ABUS leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by INTC simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, ABUS or INTC?

Analyst price targets imply not covered upside for ABUS and +75.8% for INTC. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ABUS or INTC?

ABUS is the better-valued of the two on the peer-relative Value factor. ABUS on the peer-relative Value factor, by 45 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ABUS or INTC?

INTC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ABUS or INTC?

ABUS on the Momentum factor, by 21 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ABUS or INTC?

ABUS is the more resilient of the two, so the other name carries the higher downside risk. ABUS on Risk Resilience, by 33 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ABUS more profitable than INTC?

ABUS leads on the comparable margin measures — gross margin 100% vs 40.2%; operating margin 79.9% vs 3.2%; ttm roe 68.9% vs 2.9%.

Is ABUS's lead over INTC getting stronger or weaker?

ABUS lead: Strengthening — the AIQ differential moved from 16 to 34 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ABUS vs INTC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: INTC closes the Value gap — currently 45 points behind, the largest single contributor to ABUS's edge; INTC's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; ABUS's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ABUS and INTC?

ABUS: 2 bullish / 3 bearish / 1 neutral, conflicted. INTC: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABUS is Death Cross Active (bearish, long horizon). On INTC it is Golden Cross Active (bullish, long horizon).

Compare ABUS and INTC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.